Terms: = Kidney tumors AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
6 results:
1. Beyond the genome: malat1's role in advancing urologic cancer care.
Imran M; Abida ; Eltaib L; Siddique MI; Kamal M; Asdaq SMB; Singla N; Al-Hajeili M; Alhakami FA; AlQarni AF; Abdulkhaliq AA; Rabaan AA
Pathol Res Pract; 2024 Apr; 256():155226. PubMed ID: 38452585
[TBL] [Abstract] [Full Text] [Related]
2. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
Zhou L; Ye J; Wen F; Yu H
Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
[TBL] [Abstract] [Full Text] [Related]
4. Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of malat1.
Jin C; Shi L; Li K; Liu W; Qiu Y; Zhao Y; Zhao B; Li Z; Li Y; Zhu Q
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278501
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA malat1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract] [Full Text] [Related]
6. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract] [Full Text] [Related]
